SHANNON GALPIN: Open Payments
NPI 1083341903 · KLAMATH FALLS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 17 payments from 10 companies in 2025. Trend: 2023 $163 · 2024 $355 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $47 |
| ABBVIE INC. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $38 |
| Amgen Inc. | 2 | $38 |
| Antares Pharma, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $33 |
| Lundbeck LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $19 |
| PFIZER INC. | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: Veozah, OTEZLA, XYOSTED, MOUNJARO, Wegovy, REXULTI, UBRELVY, QULIPTA.
Industry payments across OR — which companies pay providers there.
